OT VERIO2 METER
Report
- Report Number
- 3008382007-2017-20386
- Event Type
- Injury
- Date Received
- May 2, 2017
- Report Date
- April 25, 2017
- Manufacturer
- LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL
- Product Code
- NBW
- UDI-DI
- 00353885008730
- PMA / PMN Number
- K131363
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- SC, US
- Reporter Occupation
- PATIENT
Narratives
THE LAY USER/PATIENT¿S METER AND TEST STRIPS HAVE BEEN RETURNED AND EVALUATED BY LIFESCAN PRODUCT ANALYSIS WITH THE FOLLOWING FINDINGS: THE TEST STRIPS HAVE PASSED ALL TESTING WITH NO FAULTS FOUND. THE REPORTED ISSUE COULD NOT BE CONFIRMED. IN ADDITION, LIFESCAN CONDUCTED AN EVALUATION OF THE TEST STRIP LOT AND CONCLUDED THAT THIS LOT DID NOT BREACH THE THRESHOLDS SET FOR ESCALATION AND NO SYSTEMIC ISSUE WAS OBSERVED. ANALYSIS WAS NOT POSSIBLE FOR THE RETURNED METER DUE TO UNKNOWN STORAGE AND HANDLING PREVENTING THE ALLEGATION BEING PHYSICALLY INVESTIGATED. IF LIFESCAN OBTAINS ADDITIONAL INFORMATION REGARDING THIS COMPLAINT, A FOLLOW-UP REPORT WILL BE SUBMITTED. AT THIS TIME, LIFESCAN CONSIDERS THIS MATTER CLOSED.
ON (B)(6) 2017 THE LAY USER/PATIENT CONTACTED LIFESCAN (LFS) ALLEGING THAT HER ONETOUCH VERIO2 METER WAS READING INACCURATELY WHEN TESTING WITH CONTROL SOLUTION. THE COMPLAINT WAS CLASSIFIED BASED ON THE CUSTOMER SERVICE REPRESENTATIVE (CSR) DOCUMENTATION. THE PATIENT STATED THAT THE ALLEGED INACCURACY ISSUE BEGAN ¿A FEW WEEKS AGO¿ WHEN A READING OF 137MG/DL WAS OBTAINED WHEN CHECKING THE SUBJECT DEVICE WITH CONTROL SOLUTION. THE PATIENT STATED THAT SHE DOES NOT TAKE ANY MEDICATIONS TO MANAGE HER DIABETES AND REPORTEDLY CONTINUED WITH HER USUAL DIABETES MANAGEMENT ROUTINE AFTER THE REPORTED ISSUE BEGAN. THE PATIENT STATED THAT SHE EXPERIENCED SYMPTOMS OF ¿BLURRED VISION, SHAKY AND SWEATING¿ RIGHT AWAY AFTER THE ALLEGED ISSUE BEGAN. THE PATIENT DENIED RECEIVING ANY FORM OF MEDICAL INTERVENTION IN RESPONSE TO THE REPORTED EVENT. AT THE TIME OF TROUBLESHOOTING, THE CSR CONFIRMED THAT THE METER WAS SET WITH THE CORRECT UNIT OF MEASURE AND THE CORRECT CONTROL SOLUTION WAS BEING USED. THE CSR NOTED THAT THE RESULT FELL WITHIN THE SPECIFIED CONTROL RANGE OF ¿102 -138 MG/DL¿ FOR TEST STRIP LOT # 4169839. THE CSR REQUESTED THE PRODUCTS BACK FOR INVESTIGATION AND REPLACEMENT PRODUCTS WERE SENT TO THE PATIENT. THIS COMPLAINT IS BEING REPORTED BECAUSE THE PATIENT REPORTEDLY DEVELOPED SIGNS AND/OR SYMPTOMS THAT MEET LFS¿ CRITERIA FOR A SERIOUS INJURY REPORTABLE ADVERSE EVENT AFTER THE ALLEGED PRODUCT ISSUE BEGAN.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 318801 | OT VERIO2 METER | GLUCOSE MONITORING SYS/KIT | NBW | LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL | 4169839 | 00353885008730 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Life Threatening |